SlideShare a Scribd company logo
1 of 25
DRUGS ACTING ON CNS-
ANTICONVULSANTS
ANTICONVULSANTS
PREPARED BY:
MS. JYOTI RANI
ASSISTANT PROFESSOR
BUEST,SPES
What is Epilepsy ?
Recognised from the dawn of history as ‘disease of lightening’, it was correctly
described by JH Jackson little over a century ago.
 Epilepsy is a chronic disorder that causes unprovoked, recurrent seizures.
 A seizure is a sudden rush of electrical activity in the brain i.e. related to ‘depolarization
shift’ which consists of a synchronous and unusually large depolarization over which
shift’ which consists of a synchronous and unusually large depolarization over which
action potentials are superimposed.
 A mild seizure may be difficult to recognize. It can last a few seconds during which you
lack awareness.
 Stronger seizures can cause spasms and uncontrollable muscle twitches, and can last a
few seconds to several minutes. During a stronger seizure, some people become confused
or lose consciousness. Afterward you may have no memory of it happening.
Types of Epilepsy
Generalized Seizures (affect the whole brain)
1. Absence seizures, which used to be called “petit mal
seizures,” cause a blank stare. This type of seizure may
also cause repetitive movements like lip smacking or
blinking. There’s also usually a short loss of awareness.
2. Tonic seizures cause muscle stiffness.
3. Atonic seizures lead to loss of muscle control and can
make you fall down suddenly.
Focal/Partial Seizures (affect just one part of the
brain)
1. A simple partial seizure doesn’t involve loss of
consciousness. Symptoms include:
• alterations to sense of taste, smell, sight, hearing, or
touch
• dizziness
• tingling and twitching of limbs
make you fall down suddenly.
4. Clonic seizures are characterized by repeated, jerky
muscle movements of the face, neck, and arms.
5. Myoclonic seizures cause spontaneous quick twitching
of the arms and legs.
6. Tonic-clonic seizures used to be called “grand mal
seizures.” Symptoms include:
• stiffening of the body
• shaking
• loss of bladder or bowel control
• biting of the tongue
• loss of consciousness
• tingling and twitching of limbs
2. Complex partial seizures involve loss of
awareness or consciousness. Other symptoms
include:
• staring blankly
• unresponsiveness
• performing repetitive movements
CLASSIFICATION OF ANTI-CONVULSANTS
 Barbiturates: Phenobarbitone, Metharbital.
 Hydantoins: Phenytoin*, Mephenytoin, Ethotoin
 Oxazolidine diones:Trimethadione, Paramethadione
 Oxazolidine diones:Trimethadione, Paramethadione
 Succinimides: Phensuximide, Methsuximide, Ethosuximide*
 Urea and monoacyl ureas: Phenacemide,
 Benzodiazepines: Carbamazepine *, Clonazepam
 Miscellaneous: Primidone, Valproic acid , Gabapentin, Felbamate
Mechanism of Action of anticonvulsants
 Anticonvulsants have a stabilizing
influence on neuronal membrane—prevents
repetitive detonation of normal brain cells
during ‘depolarization shift’ where
intracellular accumulation of Na+ that
occurs during repetitive firing is prevented.
 This is achieved by prolonging the
inactivated state of voltage sensitive
inactivated state of voltage sensitive
neuronal Na+ channel that governs the
refractory period of the neurone.
 As a result high frequency discharges are
inhibited also allows Na+ channels to
recover even when their inactivation is
prolonged.
 While other effects are like
 reduction in Ca2+ influx,
 facilitation of GABA responses.
SAR of Anticonvulsants
 Many of the standard Anticonvulsants
that contain the ureide structure, as
shown in Figure,
 These have been used clinically for more
 These have been used clinically for more
than 30 years without much change in
their ureide structures.
 Small changes in the X substituent of the
ureide structure can cause significant
changes in the type of seizures
controlled.
Barbiturates
Phenobarbitone
O
N
H
O
HN
O
CH2
CH3
1
2
3
5
4
6
MOA. Mechanism is likely related to the potentiation of GABA
inhibition in
the CNS. Barbiturates also antagonize glutamate excitation.
Clinical uses.
1. Phenobarbital is orally administered in the treatment of grand
5-ethyl-5-phenylpyrimidine-
2,4,6(1H,3H,5H)-trione
Phenobarbitone
1. Phenobarbital is orally administered in the treatment of grand
mal epilepsy.
2. It is less effective in the treatment of petit mal and
psychomotor epilepsies.
3. The injectable from of the drug is used to treat other types of
convulsions.
Adverse effects.
sedation, dizziness, drowsiness, ataxia (lack of muscular
coordination), and nystagmus (a rapid
involuntary movement of the eyeball).
O
N
O
HN
O
Metharbital
It is a barbiturate anticonvulsant. It has similar properties
to Phenobarbital.
Pharmacology. It belongs to a group of medicines called central
nervous system (CNS) depressants that induce drowsiness and
relieve tension or nervousness. Little analgesia is conferred by
barbiturates; their use in the presence of pain may result in
excitation.
Metharbital
5,5-diethyl-1-
methylpyrimidine-
2,4,6(1H,3H,5H)-trione
excitation.
MOA. binds at the GABAA receptor, leading to Cl- ionopore
openening. The post-synaptic inhibitory effect of GABA in the
thalamus is, therefore, prolonged. Barbiturates also causes direct
inhibition of excitatory AMPA type glutamate receptors, resulting in
a profound suppression of glutamatergic neurotransmission.
Use. It is used for the treatment of short term insomnia and in the
treatment of epilepsy.
Hydantoins-SAR
1. Hydantoins are cyclic monoacylureas. They possess imidazoline-2, 4-dione
heterocyclic system. Hydantoins are structurally related to barbiturates,
differing in lacking the 6-oxo moiety.
2. Hydantoins are weakly acidic than barbiturates. Thus aqueous solution of
sodium salts provide strongly alkaline solutions.
3. A clinically useful hydantoin possess an aryl substituent at the 5-position.
N
H
O
NH
O
Hydantoin
1
3
2
4
5
4. Hydantoin derivatives possessing of lower alkyl substituents have antiabsence
activity.
Phenytoin
N
H
O
NH
O
Phenytoin
5,5-diphenylimidazolidine
-2,4-dione
Phenytoin is a first line antiepileptic drug, but less commonly used
now because side effects are frequent and marginal overdose causes
steep rise in plasma concentration, producing neurotoxicity.
MOA. Phenytoin probably works by maintaining the deactivation of
voltage-sensitive sodium channels, thereby blocking the repetitive
firing of neurons.
Synthesis. Phenytoin may be synthesized by heating α-bromo-
diphenylacetylurea with alcoholic ammonia.
Clinical uses
1. Phenytoin is used alone or in
combination with phenobarbital
in the treatment of grand mal and
psychomotor epilepsy.
2. It is also used in the treatment of
other types of convulsions.
N
H
O
N
O
1
3
2
4
5
CH3
H2C
H3C
Mephenytoin
5-ethyl-3-methyl-5-
phenylimidazolidine-2,4-dione
Mephenytoin
It is a hydantoin, used as an anticonvulsant. It was introduced
approximately 10 years after phenytoin, in the late 1940s.
Clinical uses
1. Mephenytoin is used to control seizures in combination with
phenytoin.
2. It is used as a reserve drug (only when phenytoin has failed),
because the metabolic product (5-ethyl-5-phenylhydantoin) of
because the metabolic product (5-ethyl-5-phenylhydantoin) of
mephenytoin is highly toxic.
Ethotoin
is an anticonvulsant drug used in the treatment of epilepsy. It is
a hydantoin, similar to phenytoin.
Clinical uses.
Ethotoin is indicated for tonic-clonic and partial complex seizures.
Oxazolidine diones
Oxazolidinediones were introduced as anticonvulsants in 1948.
They possess the following heterocyclic system :
Oxazolidine-2, 4-dione is analogous to hydantoin differs in having of
oxygen atom at position-1 instead of NH.
Trimethadione (Troxidone)
1
2
3
4
5
N
O
O
O
Trimethadione
3,5,5-
trimethyloxazolidine-
2,4-dione
It is an oxazolidinedione anticonvulsant. It is most
commonly used to treat epileptic conditions that are resistant
to other treatments.
Clinical uses. Troxidone is used in the treatment of absence
seizures
Paramethadione
It differs from trimethadione only in the substitution of one methyl
group with an ethyl group .
Paramethadione (brand name Paradione) is an anticonvulsant in
the oxazolidinedione class developed by the Illinois-based
pharmaceutical company Abbott Laboratories (known
as AbbVie since January 1, 2013 ).
MOA. Paramethadione acts to reduce T-type calcium currents in
thalamic neurons which has been proposed to underlie the 3-Hz
spike-and-wave discharge seen on electroencephalogram (EEG)
during absence seizures.
Uses.
It was approved by the Food and Drug Administration in 1949 for
the treatment of absence seizures, also called partial seizures.
Succinimides
Oxazolidinediones are toxic hence to replace them with less toxic drugs
succinimides were introduced in 1951 as antiepileptics.
The precise mechanism of action of succinimides is unknown. It has been
postulated that succinimides enhances inhibitory processes in the brain,
by some effect on specific inhibitory neurotransmitter systems.
Succinimides refers to compounds that contain the succinimide group.
Succinimides refers to compounds that contain the succinimide group.
These compounds have some notable uses.
Several succinimides are used as anticonvulsant drugs, including
 ethosuximide,
 phensuximide, and
 methsuximide.
Ethosuximide
Ethosuximide is considered the first choice drug for treating
absence seizures in part because it lacks the idiosyncratic
hepatotoxicity of the alternative anti-absence drug, valproic acid.
MOA. Ethosuximide binds with T-type voltage sensitive calcium
channels. The latter involves in mediating the entry of calcium
ions into excitable cells and are also involves in variety of
calcium-dependent processes, including muscle contraction,
calcium-dependent processes, including muscle contraction,
hormone release, neurotransmitter release, gene expression, cell
division and cell death.
T-type voltage sensitive calcium channel are also involved in the
modulation of firing patterns or neurons which is necessary for
the information processing and also in cell growth processes.
Use.
Ethosuximide is used for:
The control and prevention of absence or petit mal seizure
Synthesis.
i. Methylethylketone and cyanoacetic ester are condensed in Knoevanagel reaction conditions.
ii. Hydrogen cyanide is added to the resulting product.
iii. Dinitrile so formed undergoes acidic hydrolysis and decarboxylation to form 2-methyl-2-
ethylsucinic acid.
iv. Reaction of the above formed compound with ammonia gives a diazonium salt which on
heterocyclization produces ethosuximide.
Phensuximide
Phensuximide
O
N
O
Phensuximide is a member of the succinimide class with
anticonvulsant properties.
MOA. It suppresses the paroxysmal three cycle per second spike
and wave EEG pattern associated with lapses of consciousness in
petit mal seizures.
It's effects may be related to its ability to inhibit depolarization-
1-methyl-3-
phenylpyrrolidine-2,5-
dione
It's effects may be related to its ability to inhibit depolarization-
induced accumulation of cyclic AMP and cyclic GMP in brain
tissue.
Thus the frequency of attacks is reduced by depression of nerve
transmission in the motor cortex.
Clinical uses. Phensuximide belongs succinimide class of
antiepileptic agent used to treat convulsions but it is reported to
be less effective
Methsuximide
Mesuximide (or methsuximide, methosuximide) is
a succinimide anticonvulsant medication.
MOA. It is thought to owe its activity to its major metabolite
N-desmethylmethsuccimide.
Clinical use.
methsuximide
O
N
O
Clinical use.
1. Methsuximide is a succinimide antiepileptic agent used
to treat complex partial seizures.
2. is indicated for the control of absence seizures that are
refractory to other drugs.
1,3-dimethyl-3-
phenylpyrrolidine-2,5-dione
Urea and monoacyl ureas
Phenacemide
 also known as phenylacetylurea, is an anticonvulsant of
the ureide (acetylurea) class.
 It is a congener and ring open analog of
phenytoin (a hydantoin) and
phenytoin (a hydantoin) and
 It is structurally related to the barbiturates and to
other hydantoins.
 Phenacemide was introduced in 1949 for the treatment
of epilepsy, but was eventually withdrawn due to toxicity.
Benzodiazepines
Carbamazepine *
is an anticonvulsant medication used primarily in the
treatment of epilepsy and neuropathic pain. It is used
in schizophrenia along with other medications and as a
second-line agent in bipolar disorder.
Synthesis. Reaction of 5H-dibenz[b,f]azepine with potassium
Carbamazepine
N
O NH2
5H-dibenzo[b,f]azepine-5-
carboxamide
Synthesis. Reaction of 5H-dibenz[b,f]azepine with potassium
cyanate to get carbamazepine.
carboxamide
Uses.
1. It is used to control grandmal
and focal seizures.
2. It is also used in the treatment
of trigeminal neuralgia and
3. the treatment of manic
4. depression.
Clonazepam
It is a medication used to prevent and treat seizures, panic disorder,
and the movement disorder known as akathisia.
It is a tranquilizer of the benzodiazepine class. It is taken orally.
Effects begin within one hour and last between six and twelve hours.
Clinical uses.
1. Clonazepam is used in the treatment of grand mal epilepsy.
2. It is the alternate drug for the treatment of petit mal in patients
who fail to respond to ethosuximide therapy.
3. It suppresses various types of status epilepticus seizures but
because of its cardiorespiratory depressant effect, it is second to
diazepam.
Miscellaneous
Valproic acid
• Valproic acid is not chemically related to other anticonvulsants.
• Valproic acid is a branched short-chain fatty acid (SCFA) made
from valeric acid.
MOA. Valproate's precise mechanism of action is unclear.
O OH
Valproic acid
2-propylpentanoic acid
MOA. Valproate's precise mechanism of action is unclear.
Proposed mechanisms include affecting GABA levels,
blocking voltage-gated sodium channels, and inhibiting histone
deacetylases.
Use.
1. It is used primarily to treat epilepsy and bipolar disorder.
2. It is also used to prevent migraine headaches.
Primidone
Primidone is an antiepileptic agent related to barbiturates.
Primidone is a diketone derived from hexahydropyrimidine.
Use.
It is used to treat partial and generalized seizures, as well
as essential tremors. It is taken by mouth.
O
N
H
HN
O
5-ethyl-5-
phenyldihydropyrimidin
e-4,6(1H,5H)-dione
Primidone
e-4,6(1H,5H)-dione
O
NH2
O
O
H2N
O
2-phenylpropane-1,3-diyl
dicarbamate
Felbamate Felbamate
is an anticonvulsant. used in the treatment of epilepsy.
It is used to treat partial seizures (with and without
generalization) in adults and partial and generalized
seizures associated with Lennox–Gastaut syndrome (LGS)
is a complex, rare, and severe childhood-onset epilepsy in
children.
Gabapentin
Gabapentin containing primary amino and carboxyl groups,
is better represented as an internal salt resulting from
proton transfer from the acidic carboxyl group to the basic
amino group.
MOA.The name and structure again suggests GABA
mediated pharmacology but surprisinglythe mechanism of
action remains unknown.
Gabapentin
O
HO
NH2
2-(1-(aminomethyl)cyclo
hexyl)acetic acid
action remains unknown.
Uses.
1. It is an anticonvulsant medication primarily used to
treat partial seizures and neuropathic pain.
2. It is a first-line medication for the treatment of
neuropathic pain caused by diabetic
neuropathy, postherpetic neuralgia, and central pain.
hexyl)acetic acid
Thank You

More Related Content

What's hot

ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...
ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...
ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...Dr. Ravi Sankar
 
Parasympathomimetics medicinal chemistry b. pharm.
Parasympathomimetics   medicinal chemistry    b. pharm. Parasympathomimetics   medicinal chemistry    b. pharm.
Parasympathomimetics medicinal chemistry b. pharm. AZCPh
 
General Anaesthesia (Medicinal Chemistry)
General Anaesthesia (Medicinal Chemistry)General Anaesthesia (Medicinal Chemistry)
General Anaesthesia (Medicinal Chemistry)Yogesh Tiwari
 
Antihyperlipidemic agents
Antihyperlipidemic agentsAntihyperlipidemic agents
Antihyperlipidemic agentskencha swathi
 
CHOLINERGIC BLOCKERS(CHOLINOLYTICS)
CHOLINERGIC BLOCKERS(CHOLINOLYTICS)CHOLINERGIC BLOCKERS(CHOLINOLYTICS)
CHOLINERGIC BLOCKERS(CHOLINOLYTICS)kencha swathi
 
Benzodiazopines SAR by dr. khalid hussain
Benzodiazopines SAR by dr. khalid hussainBenzodiazopines SAR by dr. khalid hussain
Benzodiazopines SAR by dr. khalid hussainZeeshan Naseer
 
SAR and Synthesis of adrenergic blockers
SAR and Synthesis of adrenergic blockersSAR and Synthesis of adrenergic blockers
SAR and Synthesis of adrenergic blockersDrParthiban1
 
Unit 3 Drugs Affecting PNS (As per PCI syllabus)
Unit 3 Drugs Affecting PNS (As per PCI syllabus)Unit 3 Drugs Affecting PNS (As per PCI syllabus)
Unit 3 Drugs Affecting PNS (As per PCI syllabus)Mirza Anwar Baig
 
ORAL HYPOGLYCEMIC AGENTS MEDICINAL CHEMISTRY
ORAL HYPOGLYCEMIC AGENTS MEDICINAL CHEMISTRYORAL HYPOGLYCEMIC AGENTS MEDICINAL CHEMISTRY
ORAL HYPOGLYCEMIC AGENTS MEDICINAL CHEMISTRYSaurabh Badole
 
3rd unit anti-hyperlipidemic agents ppt
3rd  unit  anti-hyperlipidemic  agents ppt3rd  unit  anti-hyperlipidemic  agents ppt
3rd unit anti-hyperlipidemic agents pptNikithaGopalpet
 
HMG-CoA reductase inhibitors.pptx
HMG-CoA reductase inhibitors.pptxHMG-CoA reductase inhibitors.pptx
HMG-CoA reductase inhibitors.pptxDr. Manoj Kumbhare
 
g. Antirheumatic drugs.pdf
g. Antirheumatic drugs.pdfg. Antirheumatic drugs.pdf
g. Antirheumatic drugs.pdfVISHALJADHAV100
 
Antihypertensive agents
Antihypertensive agentsAntihypertensive agents
Antihypertensive agentskencha swathi
 
Medicinal chemistry, sympathomimetic agents, unit-2 ,4th sem
Medicinal chemistry, sympathomimetic agents, unit-2 ,4th semMedicinal chemistry, sympathomimetic agents, unit-2 ,4th sem
Medicinal chemistry, sympathomimetic agents, unit-2 ,4th semsnigdharanibehera
 
CNS stimulants and cognitive enhancers
CNS stimulants and cognitive enhancersCNS stimulants and cognitive enhancers
CNS stimulants and cognitive enhancersMahi Yeruva
 
3rd unit anti-arrhythmic drugs
3rd unit anti-arrhythmic drugs3rd unit anti-arrhythmic drugs
3rd unit anti-arrhythmic drugsNikithaGopalpet
 

What's hot (20)

ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...
ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...
ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...
 
Parasympathomimetics medicinal chemistry b. pharm.
Parasympathomimetics   medicinal chemistry    b. pharm. Parasympathomimetics   medicinal chemistry    b. pharm.
Parasympathomimetics medicinal chemistry b. pharm.
 
General Anaesthesia (Medicinal Chemistry)
General Anaesthesia (Medicinal Chemistry)General Anaesthesia (Medicinal Chemistry)
General Anaesthesia (Medicinal Chemistry)
 
Antianginal drugs
Antianginal drugsAntianginal drugs
Antianginal drugs
 
Antihyperlipidemic agents
Antihyperlipidemic agentsAntihyperlipidemic agents
Antihyperlipidemic agents
 
CHOLINERGIC BLOCKERS(CHOLINOLYTICS)
CHOLINERGIC BLOCKERS(CHOLINOLYTICS)CHOLINERGIC BLOCKERS(CHOLINOLYTICS)
CHOLINERGIC BLOCKERS(CHOLINOLYTICS)
 
Anticonvulsants
AnticonvulsantsAnticonvulsants
Anticonvulsants
 
Benzodiazopines SAR by dr. khalid hussain
Benzodiazopines SAR by dr. khalid hussainBenzodiazopines SAR by dr. khalid hussain
Benzodiazopines SAR by dr. khalid hussain
 
SAR and Synthesis of adrenergic blockers
SAR and Synthesis of adrenergic blockersSAR and Synthesis of adrenergic blockers
SAR and Synthesis of adrenergic blockers
 
Unit 3 Drugs Affecting PNS (As per PCI syllabus)
Unit 3 Drugs Affecting PNS (As per PCI syllabus)Unit 3 Drugs Affecting PNS (As per PCI syllabus)
Unit 3 Drugs Affecting PNS (As per PCI syllabus)
 
ORAL HYPOGLYCEMIC AGENTS MEDICINAL CHEMISTRY
ORAL HYPOGLYCEMIC AGENTS MEDICINAL CHEMISTRYORAL HYPOGLYCEMIC AGENTS MEDICINAL CHEMISTRY
ORAL HYPOGLYCEMIC AGENTS MEDICINAL CHEMISTRY
 
3rd unit anti-hyperlipidemic agents ppt
3rd  unit  anti-hyperlipidemic  agents ppt3rd  unit  anti-hyperlipidemic  agents ppt
3rd unit anti-hyperlipidemic agents ppt
 
HMG-CoA reductase inhibitors.pptx
HMG-CoA reductase inhibitors.pptxHMG-CoA reductase inhibitors.pptx
HMG-CoA reductase inhibitors.pptx
 
g. Antirheumatic drugs.pdf
g. Antirheumatic drugs.pdfg. Antirheumatic drugs.pdf
g. Antirheumatic drugs.pdf
 
Antihypertensive agents
Antihypertensive agentsAntihypertensive agents
Antihypertensive agents
 
Medicinal chemistry, sympathomimetic agents, unit-2 ,4th sem
Medicinal chemistry, sympathomimetic agents, unit-2 ,4th semMedicinal chemistry, sympathomimetic agents, unit-2 ,4th sem
Medicinal chemistry, sympathomimetic agents, unit-2 ,4th sem
 
CNS stimulants and cognitive enhancers
CNS stimulants and cognitive enhancersCNS stimulants and cognitive enhancers
CNS stimulants and cognitive enhancers
 
3rd unit anti-arrhythmic drugs
3rd unit anti-arrhythmic drugs3rd unit anti-arrhythmic drugs
3rd unit anti-arrhythmic drugs
 
Sympathomimmetic agents
Sympathomimmetic agentsSympathomimmetic agents
Sympathomimmetic agents
 
Medicinal Chemistry of Diuretics
Medicinal Chemistry of DiureticsMedicinal Chemistry of Diuretics
Medicinal Chemistry of Diuretics
 

Similar to Drugs acting on cns anticonvulsants

Anti convulsant drugs
Anti convulsant drugs Anti convulsant drugs
Anti convulsant drugs Ramya Reddy
 
Antiepileptic drugs : Dr Rahul Kunkulol's Power point preparations
Antiepileptic drugs : Dr Rahul Kunkulol's Power point preparationsAntiepileptic drugs : Dr Rahul Kunkulol's Power point preparations
Antiepileptic drugs : Dr Rahul Kunkulol's Power point preparationsRahul Kunkulol
 
Anticonvulsant (Antiepileptics)-converted.pptx
Anticonvulsant   (Antiepileptics)-converted.pptxAnticonvulsant   (Antiepileptics)-converted.pptx
Anticonvulsant (Antiepileptics)-converted.pptxMohammedBasit5
 
SEDATIVE-hypnotics-epilepsy 1 3.pdf pharma
SEDATIVE-hypnotics-epilepsy 1 3.pdf pharmaSEDATIVE-hypnotics-epilepsy 1 3.pdf pharma
SEDATIVE-hypnotics-epilepsy 1 3.pdf pharmaNimaFartash
 
Unit V general anaesthestics.pptx
Unit V general anaesthestics.pptxUnit V general anaesthestics.pptx
Unit V general anaesthestics.pptxSamruddhi Khonde
 
ANTICONVULSANT DRUGS.pptx-classification mechanism structure synthesis
ANTICONVULSANT DRUGS.pptx-classification mechanism structure synthesisANTICONVULSANT DRUGS.pptx-classification mechanism structure synthesis
ANTICONVULSANT DRUGS.pptx-classification mechanism structure synthesisChinnu Suresh
 
ANTICONVULSANTS (1) (1).pdf
ANTICONVULSANTS (1) (1).pdfANTICONVULSANTS (1) (1).pdf
ANTICONVULSANTS (1) (1).pdfEducation
 
Anti epileptic agents or drugs pharmacology
Anti epileptic agents or drugs pharmacologyAnti epileptic agents or drugs pharmacology
Anti epileptic agents or drugs pharmacologysonalinghatmal
 
Antiepilepticdrugs(Harbhusan Gain, Student, Dept. of Pharmacy,World Universit...
Antiepilepticdrugs(Harbhusan Gain, Student, Dept. of Pharmacy,World Universit...Antiepilepticdrugs(Harbhusan Gain, Student, Dept. of Pharmacy,World Universit...
Antiepilepticdrugs(Harbhusan Gain, Student, Dept. of Pharmacy,World Universit...University of Dhaka
 

Similar to Drugs acting on cns anticonvulsants (20)

Antiepiletics
AntiepileticsAntiepiletics
Antiepiletics
 
Anticonvulsant notes
Anticonvulsant notesAnticonvulsant notes
Anticonvulsant notes
 
Anti convulsant drugs
Anti convulsant drugs Anti convulsant drugs
Anti convulsant drugs
 
Antiepileptic drugs : Dr Rahul Kunkulol's Power point preparations
Antiepileptic drugs : Dr Rahul Kunkulol's Power point preparationsAntiepileptic drugs : Dr Rahul Kunkulol's Power point preparations
Antiepileptic drugs : Dr Rahul Kunkulol's Power point preparations
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Antiepileptics
AntiepilepticsAntiepileptics
Antiepileptics
 
Anticonvulsant (Antiepileptics)-converted.pptx
Anticonvulsant   (Antiepileptics)-converted.pptxAnticonvulsant   (Antiepileptics)-converted.pptx
Anticonvulsant (Antiepileptics)-converted.pptx
 
SEDATIVE-hypnotics-epilepsy 1 3.pdf pharma
SEDATIVE-hypnotics-epilepsy 1 3.pdf pharmaSEDATIVE-hypnotics-epilepsy 1 3.pdf pharma
SEDATIVE-hypnotics-epilepsy 1 3.pdf pharma
 
Unit V general anaesthestics.pptx
Unit V general anaesthestics.pptxUnit V general anaesthestics.pptx
Unit V general anaesthestics.pptx
 
ANTICONVULSANT DRUGS.pptx-classification mechanism structure synthesis
ANTICONVULSANT DRUGS.pptx-classification mechanism structure synthesisANTICONVULSANT DRUGS.pptx-classification mechanism structure synthesis
ANTICONVULSANT DRUGS.pptx-classification mechanism structure synthesis
 
Anti convulsant drugs 2..pptx
Anti convulsant drugs 2..pptxAnti convulsant drugs 2..pptx
Anti convulsant drugs 2..pptx
 
New Antiepileptic drugs Dr.Rahul.pptx
New Antiepileptic drugs Dr.Rahul.pptxNew Antiepileptic drugs Dr.Rahul.pptx
New Antiepileptic drugs Dr.Rahul.pptx
 
ANTICONVULSANTS (1) (1).pdf
ANTICONVULSANTS (1) (1).pdfANTICONVULSANTS (1) (1).pdf
ANTICONVULSANTS (1) (1).pdf
 
Ankita gaidhane ppt
Ankita gaidhane pptAnkita gaidhane ppt
Ankita gaidhane ppt
 
39.ANTIEPILEPTIC DRUGS.ppt
39.ANTIEPILEPTIC DRUGS.ppt39.ANTIEPILEPTIC DRUGS.ppt
39.ANTIEPILEPTIC DRUGS.ppt
 
ANTI-EPILEPTIC DRUGS
ANTI-EPILEPTIC DRUGSANTI-EPILEPTIC DRUGS
ANTI-EPILEPTIC DRUGS
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Pharm test6
Pharm test6Pharm test6
Pharm test6
 
Anti epileptic agents or drugs pharmacology
Anti epileptic agents or drugs pharmacologyAnti epileptic agents or drugs pharmacology
Anti epileptic agents or drugs pharmacology
 
Antiepilepticdrugs(Harbhusan Gain, Student, Dept. of Pharmacy,World Universit...
Antiepilepticdrugs(Harbhusan Gain, Student, Dept. of Pharmacy,World Universit...Antiepilepticdrugs(Harbhusan Gain, Student, Dept. of Pharmacy,World Universit...
Antiepilepticdrugs(Harbhusan Gain, Student, Dept. of Pharmacy,World Universit...
 

More from Baddi University of Emerging sciences and Technology (7)

Drugs Acting on CNS-Antipsychotics
Drugs Acting on CNS-AntipsychoticsDrugs Acting on CNS-Antipsychotics
Drugs Acting on CNS-Antipsychotics
 
3 D QSAR Approaches and Contour Map Analysis
3 D QSAR Approaches and Contour Map Analysis3 D QSAR Approaches and Contour Map Analysis
3 D QSAR Approaches and Contour Map Analysis
 
Drugs acting on cns sedative and hypnotics
Drugs acting on cns sedative and hypnoticsDrugs acting on cns sedative and hypnotics
Drugs acting on cns sedative and hypnotics
 
Drugs acting on cns general anaesthics
Drugs acting on cns general anaesthicsDrugs acting on cns general anaesthics
Drugs acting on cns general anaesthics
 
Overview of the autonomic nervous system
Overview of the autonomic nervous systemOverview of the autonomic nervous system
Overview of the autonomic nervous system
 
Adrenergics and anti adrenergics
Adrenergics and anti adrenergicsAdrenergics and anti adrenergics
Adrenergics and anti adrenergics
 
Cholinergics and anti cholinergic drugs
Cholinergics and anti cholinergic drugsCholinergics and anti cholinergic drugs
Cholinergics and anti cholinergic drugs
 

Recently uploaded

Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingTeacherCyreneCayanan
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfChris Hunter
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxnegromaestrong
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfAyushMahapatra5
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin ClassesCeline George
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...KokoStevan
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfSanaAli374401
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docxPoojaSen20
 

Recently uploaded (20)

Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 

Drugs acting on cns anticonvulsants

  • 1. DRUGS ACTING ON CNS- ANTICONVULSANTS ANTICONVULSANTS PREPARED BY: MS. JYOTI RANI ASSISTANT PROFESSOR BUEST,SPES
  • 2. What is Epilepsy ? Recognised from the dawn of history as ‘disease of lightening’, it was correctly described by JH Jackson little over a century ago.  Epilepsy is a chronic disorder that causes unprovoked, recurrent seizures.  A seizure is a sudden rush of electrical activity in the brain i.e. related to ‘depolarization shift’ which consists of a synchronous and unusually large depolarization over which shift’ which consists of a synchronous and unusually large depolarization over which action potentials are superimposed.  A mild seizure may be difficult to recognize. It can last a few seconds during which you lack awareness.  Stronger seizures can cause spasms and uncontrollable muscle twitches, and can last a few seconds to several minutes. During a stronger seizure, some people become confused or lose consciousness. Afterward you may have no memory of it happening.
  • 3. Types of Epilepsy Generalized Seizures (affect the whole brain) 1. Absence seizures, which used to be called “petit mal seizures,” cause a blank stare. This type of seizure may also cause repetitive movements like lip smacking or blinking. There’s also usually a short loss of awareness. 2. Tonic seizures cause muscle stiffness. 3. Atonic seizures lead to loss of muscle control and can make you fall down suddenly. Focal/Partial Seizures (affect just one part of the brain) 1. A simple partial seizure doesn’t involve loss of consciousness. Symptoms include: • alterations to sense of taste, smell, sight, hearing, or touch • dizziness • tingling and twitching of limbs make you fall down suddenly. 4. Clonic seizures are characterized by repeated, jerky muscle movements of the face, neck, and arms. 5. Myoclonic seizures cause spontaneous quick twitching of the arms and legs. 6. Tonic-clonic seizures used to be called “grand mal seizures.” Symptoms include: • stiffening of the body • shaking • loss of bladder or bowel control • biting of the tongue • loss of consciousness • tingling and twitching of limbs 2. Complex partial seizures involve loss of awareness or consciousness. Other symptoms include: • staring blankly • unresponsiveness • performing repetitive movements
  • 4. CLASSIFICATION OF ANTI-CONVULSANTS  Barbiturates: Phenobarbitone, Metharbital.  Hydantoins: Phenytoin*, Mephenytoin, Ethotoin  Oxazolidine diones:Trimethadione, Paramethadione  Oxazolidine diones:Trimethadione, Paramethadione  Succinimides: Phensuximide, Methsuximide, Ethosuximide*  Urea and monoacyl ureas: Phenacemide,  Benzodiazepines: Carbamazepine *, Clonazepam  Miscellaneous: Primidone, Valproic acid , Gabapentin, Felbamate
  • 5. Mechanism of Action of anticonvulsants  Anticonvulsants have a stabilizing influence on neuronal membrane—prevents repetitive detonation of normal brain cells during ‘depolarization shift’ where intracellular accumulation of Na+ that occurs during repetitive firing is prevented.  This is achieved by prolonging the inactivated state of voltage sensitive inactivated state of voltage sensitive neuronal Na+ channel that governs the refractory period of the neurone.  As a result high frequency discharges are inhibited also allows Na+ channels to recover even when their inactivation is prolonged.  While other effects are like  reduction in Ca2+ influx,  facilitation of GABA responses.
  • 6. SAR of Anticonvulsants  Many of the standard Anticonvulsants that contain the ureide structure, as shown in Figure,  These have been used clinically for more  These have been used clinically for more than 30 years without much change in their ureide structures.  Small changes in the X substituent of the ureide structure can cause significant changes in the type of seizures controlled.
  • 7. Barbiturates Phenobarbitone O N H O HN O CH2 CH3 1 2 3 5 4 6 MOA. Mechanism is likely related to the potentiation of GABA inhibition in the CNS. Barbiturates also antagonize glutamate excitation. Clinical uses. 1. Phenobarbital is orally administered in the treatment of grand 5-ethyl-5-phenylpyrimidine- 2,4,6(1H,3H,5H)-trione Phenobarbitone 1. Phenobarbital is orally administered in the treatment of grand mal epilepsy. 2. It is less effective in the treatment of petit mal and psychomotor epilepsies. 3. The injectable from of the drug is used to treat other types of convulsions. Adverse effects. sedation, dizziness, drowsiness, ataxia (lack of muscular coordination), and nystagmus (a rapid involuntary movement of the eyeball).
  • 8. O N O HN O Metharbital It is a barbiturate anticonvulsant. It has similar properties to Phenobarbital. Pharmacology. It belongs to a group of medicines called central nervous system (CNS) depressants that induce drowsiness and relieve tension or nervousness. Little analgesia is conferred by barbiturates; their use in the presence of pain may result in excitation. Metharbital 5,5-diethyl-1- methylpyrimidine- 2,4,6(1H,3H,5H)-trione excitation. MOA. binds at the GABAA receptor, leading to Cl- ionopore openening. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged. Barbiturates also causes direct inhibition of excitatory AMPA type glutamate receptors, resulting in a profound suppression of glutamatergic neurotransmission. Use. It is used for the treatment of short term insomnia and in the treatment of epilepsy.
  • 9. Hydantoins-SAR 1. Hydantoins are cyclic monoacylureas. They possess imidazoline-2, 4-dione heterocyclic system. Hydantoins are structurally related to barbiturates, differing in lacking the 6-oxo moiety. 2. Hydantoins are weakly acidic than barbiturates. Thus aqueous solution of sodium salts provide strongly alkaline solutions. 3. A clinically useful hydantoin possess an aryl substituent at the 5-position. N H O NH O Hydantoin 1 3 2 4 5 4. Hydantoin derivatives possessing of lower alkyl substituents have antiabsence activity.
  • 10. Phenytoin N H O NH O Phenytoin 5,5-diphenylimidazolidine -2,4-dione Phenytoin is a first line antiepileptic drug, but less commonly used now because side effects are frequent and marginal overdose causes steep rise in plasma concentration, producing neurotoxicity. MOA. Phenytoin probably works by maintaining the deactivation of voltage-sensitive sodium channels, thereby blocking the repetitive firing of neurons. Synthesis. Phenytoin may be synthesized by heating α-bromo- diphenylacetylurea with alcoholic ammonia. Clinical uses 1. Phenytoin is used alone or in combination with phenobarbital in the treatment of grand mal and psychomotor epilepsy. 2. It is also used in the treatment of other types of convulsions.
  • 11. N H O N O 1 3 2 4 5 CH3 H2C H3C Mephenytoin 5-ethyl-3-methyl-5- phenylimidazolidine-2,4-dione Mephenytoin It is a hydantoin, used as an anticonvulsant. It was introduced approximately 10 years after phenytoin, in the late 1940s. Clinical uses 1. Mephenytoin is used to control seizures in combination with phenytoin. 2. It is used as a reserve drug (only when phenytoin has failed), because the metabolic product (5-ethyl-5-phenylhydantoin) of because the metabolic product (5-ethyl-5-phenylhydantoin) of mephenytoin is highly toxic. Ethotoin is an anticonvulsant drug used in the treatment of epilepsy. It is a hydantoin, similar to phenytoin. Clinical uses. Ethotoin is indicated for tonic-clonic and partial complex seizures.
  • 12. Oxazolidine diones Oxazolidinediones were introduced as anticonvulsants in 1948. They possess the following heterocyclic system : Oxazolidine-2, 4-dione is analogous to hydantoin differs in having of oxygen atom at position-1 instead of NH. Trimethadione (Troxidone) 1 2 3 4 5 N O O O Trimethadione 3,5,5- trimethyloxazolidine- 2,4-dione It is an oxazolidinedione anticonvulsant. It is most commonly used to treat epileptic conditions that are resistant to other treatments. Clinical uses. Troxidone is used in the treatment of absence seizures
  • 13. Paramethadione It differs from trimethadione only in the substitution of one methyl group with an ethyl group . Paramethadione (brand name Paradione) is an anticonvulsant in the oxazolidinedione class developed by the Illinois-based pharmaceutical company Abbott Laboratories (known as AbbVie since January 1, 2013 ). MOA. Paramethadione acts to reduce T-type calcium currents in thalamic neurons which has been proposed to underlie the 3-Hz spike-and-wave discharge seen on electroencephalogram (EEG) during absence seizures. Uses. It was approved by the Food and Drug Administration in 1949 for the treatment of absence seizures, also called partial seizures.
  • 14. Succinimides Oxazolidinediones are toxic hence to replace them with less toxic drugs succinimides were introduced in 1951 as antiepileptics. The precise mechanism of action of succinimides is unknown. It has been postulated that succinimides enhances inhibitory processes in the brain, by some effect on specific inhibitory neurotransmitter systems. Succinimides refers to compounds that contain the succinimide group. Succinimides refers to compounds that contain the succinimide group. These compounds have some notable uses. Several succinimides are used as anticonvulsant drugs, including  ethosuximide,  phensuximide, and  methsuximide.
  • 15. Ethosuximide Ethosuximide is considered the first choice drug for treating absence seizures in part because it lacks the idiosyncratic hepatotoxicity of the alternative anti-absence drug, valproic acid. MOA. Ethosuximide binds with T-type voltage sensitive calcium channels. The latter involves in mediating the entry of calcium ions into excitable cells and are also involves in variety of calcium-dependent processes, including muscle contraction, calcium-dependent processes, including muscle contraction, hormone release, neurotransmitter release, gene expression, cell division and cell death. T-type voltage sensitive calcium channel are also involved in the modulation of firing patterns or neurons which is necessary for the information processing and also in cell growth processes. Use. Ethosuximide is used for: The control and prevention of absence or petit mal seizure
  • 16. Synthesis. i. Methylethylketone and cyanoacetic ester are condensed in Knoevanagel reaction conditions. ii. Hydrogen cyanide is added to the resulting product. iii. Dinitrile so formed undergoes acidic hydrolysis and decarboxylation to form 2-methyl-2- ethylsucinic acid. iv. Reaction of the above formed compound with ammonia gives a diazonium salt which on heterocyclization produces ethosuximide.
  • 17. Phensuximide Phensuximide O N O Phensuximide is a member of the succinimide class with anticonvulsant properties. MOA. It suppresses the paroxysmal three cycle per second spike and wave EEG pattern associated with lapses of consciousness in petit mal seizures. It's effects may be related to its ability to inhibit depolarization- 1-methyl-3- phenylpyrrolidine-2,5- dione It's effects may be related to its ability to inhibit depolarization- induced accumulation of cyclic AMP and cyclic GMP in brain tissue. Thus the frequency of attacks is reduced by depression of nerve transmission in the motor cortex. Clinical uses. Phensuximide belongs succinimide class of antiepileptic agent used to treat convulsions but it is reported to be less effective
  • 18. Methsuximide Mesuximide (or methsuximide, methosuximide) is a succinimide anticonvulsant medication. MOA. It is thought to owe its activity to its major metabolite N-desmethylmethsuccimide. Clinical use. methsuximide O N O Clinical use. 1. Methsuximide is a succinimide antiepileptic agent used to treat complex partial seizures. 2. is indicated for the control of absence seizures that are refractory to other drugs. 1,3-dimethyl-3- phenylpyrrolidine-2,5-dione
  • 19. Urea and monoacyl ureas Phenacemide  also known as phenylacetylurea, is an anticonvulsant of the ureide (acetylurea) class.  It is a congener and ring open analog of phenytoin (a hydantoin) and phenytoin (a hydantoin) and  It is structurally related to the barbiturates and to other hydantoins.  Phenacemide was introduced in 1949 for the treatment of epilepsy, but was eventually withdrawn due to toxicity.
  • 20. Benzodiazepines Carbamazepine * is an anticonvulsant medication used primarily in the treatment of epilepsy and neuropathic pain. It is used in schizophrenia along with other medications and as a second-line agent in bipolar disorder. Synthesis. Reaction of 5H-dibenz[b,f]azepine with potassium Carbamazepine N O NH2 5H-dibenzo[b,f]azepine-5- carboxamide Synthesis. Reaction of 5H-dibenz[b,f]azepine with potassium cyanate to get carbamazepine. carboxamide Uses. 1. It is used to control grandmal and focal seizures. 2. It is also used in the treatment of trigeminal neuralgia and 3. the treatment of manic 4. depression.
  • 21. Clonazepam It is a medication used to prevent and treat seizures, panic disorder, and the movement disorder known as akathisia. It is a tranquilizer of the benzodiazepine class. It is taken orally. Effects begin within one hour and last between six and twelve hours. Clinical uses. 1. Clonazepam is used in the treatment of grand mal epilepsy. 2. It is the alternate drug for the treatment of petit mal in patients who fail to respond to ethosuximide therapy. 3. It suppresses various types of status epilepticus seizures but because of its cardiorespiratory depressant effect, it is second to diazepam.
  • 22. Miscellaneous Valproic acid • Valproic acid is not chemically related to other anticonvulsants. • Valproic acid is a branched short-chain fatty acid (SCFA) made from valeric acid. MOA. Valproate's precise mechanism of action is unclear. O OH Valproic acid 2-propylpentanoic acid MOA. Valproate's precise mechanism of action is unclear. Proposed mechanisms include affecting GABA levels, blocking voltage-gated sodium channels, and inhibiting histone deacetylases. Use. 1. It is used primarily to treat epilepsy and bipolar disorder. 2. It is also used to prevent migraine headaches.
  • 23. Primidone Primidone is an antiepileptic agent related to barbiturates. Primidone is a diketone derived from hexahydropyrimidine. Use. It is used to treat partial and generalized seizures, as well as essential tremors. It is taken by mouth. O N H HN O 5-ethyl-5- phenyldihydropyrimidin e-4,6(1H,5H)-dione Primidone e-4,6(1H,5H)-dione O NH2 O O H2N O 2-phenylpropane-1,3-diyl dicarbamate Felbamate Felbamate is an anticonvulsant. used in the treatment of epilepsy. It is used to treat partial seizures (with and without generalization) in adults and partial and generalized seizures associated with Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy in children.
  • 24. Gabapentin Gabapentin containing primary amino and carboxyl groups, is better represented as an internal salt resulting from proton transfer from the acidic carboxyl group to the basic amino group. MOA.The name and structure again suggests GABA mediated pharmacology but surprisinglythe mechanism of action remains unknown. Gabapentin O HO NH2 2-(1-(aminomethyl)cyclo hexyl)acetic acid action remains unknown. Uses. 1. It is an anticonvulsant medication primarily used to treat partial seizures and neuropathic pain. 2. It is a first-line medication for the treatment of neuropathic pain caused by diabetic neuropathy, postherpetic neuralgia, and central pain. hexyl)acetic acid